OVIDE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Ovide, and what generic alternatives are available?

Ovide is a drug marketed by Taro and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has nine patent family members in six countries.

The generic ingredient in OVIDE is malathion. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the malathion profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ovide

A generic version of OVIDE was approved as malathion by SUVEN PHARMS on May 23^rd, 2012.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for OVIDE?
What are the global sales for OVIDE?
What is Average Wholesale Price for OVIDE?

Summary for OVIDE

International Patents:	9
US Patents:	2
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	76
Patent Applications:	2,430
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for OVIDE
DailyMed Link:	OVIDE at DailyMed

Drug patent expirations by year for OVIDE

Paragraph IV (Patent) Challenges for OVIDE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
OVIDE	Topical Lotion	malathion	0.50%	018613	1	2011-03-16

US Patents and Regulatory Information for OVIDE

OVIDE is protected by two US patents.

Patents protecting OVIDE

Process for preparing malathion for pharmaceutical use
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PATIENTS INFECTED WITH PEDICULUS HUMANUS CAPITIS (HEAD LICE AND THEIR OVA) OF THE SCALP HAIR

Process for preparing malathion for pharmaceutical use
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	OVIDE	malathion	LOTION;TOPICAL	018613-001	Aug 2, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y	Y		⤷ Sign Up
Taro	OVIDE	malathion	LOTION;TOPICAL	018613-001	Aug 2, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for OVIDE

See the table below for patents covering OVIDE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	2013032405	PROCESS FOR PREPARING MALATHION FOR PHARMACEUTICAL USE	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2007005988		⤷ Sign Up
Japan	2009500422		⤷ Sign Up
Canada	2612578	PROCEDE DE PREPARATION DE MALATHION DESTINE A UN USAGE PHARMACEUTIQUE (PROCESS FOR PREPARING MALATHION FOR PHARMACEUTICAL USE)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for OVIDE

Paragraph IV (Patent) Challenges for OVIDE

Patents protecting OVIDE

Make Better Decisions: Try a trial or see plans & pricing